NASDAQ:APTO
$0.420
(
2.41%
)
Friday, 26th May 2023
Aptose Biosciences Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $0.360 | $0.580 | Friday, 26th May 2023 APTO stock ended at $0.420. This is 2.41% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 6.10% from a day low at $0.410 to a day high of $0.435. |
90 days | $0.360 | $0.675 | |
52 weeks | $0.360 | $1.05 |
Historical Aptose Biosciences prices
Date | Open | High | Low | Close | Volume |
2023-05-26 | $0.411 | $0.435 | $0.410 | $0.420 | 184 155 |
2023-05-25 | $0.450 | $0.450 | $0.360 | $0.410 | 746 993 |
2023-05-24 | $0.462 | $0.464 | $0.421 | $0.438 | 977 076 |
2023-05-23 | $0.470 | $0.480 | $0.460 | $0.476 | 361 648 |
2023-05-22 | $0.499 | $0.499 | $0.468 | $0.470 | 337 847 |
2023-05-19 | $0.478 | $0.490 | $0.460 | $0.464 | 195 186 |
2023-05-18 | $0.480 | $0.488 | $0.470 | $0.482 | 161 523 |
2023-05-17 | $0.477 | $0.496 | $0.473 | $0.478 | 175 162 |
2023-05-16 | $0.480 | $0.490 | $0.472 | $0.473 | 355 189 |
2023-05-15 | $0.510 | $0.516 | $0.472 | $0.472 | 308 014 |
2023-05-12 | $0.510 | $0.518 | $0.490 | $0.499 | 225 313 |
2023-05-11 | $0.565 | $0.565 | $0.492 | $0.496 | 165 932 |
2023-05-10 | $0.530 | $0.540 | $0.495 | $0.495 | 110 650 |
2023-05-09 | $0.470 | $0.516 | $0.470 | $0.510 | 327 061 |
2023-05-08 | $0.567 | $0.567 | $0.510 | $0.530 | 87 697 |
2023-05-05 | $0.500 | $0.550 | $0.500 | $0.540 | 304 083 |
2023-05-04 | $0.540 | $0.540 | $0.510 | $0.522 | 150 699 |
2023-05-03 | $0.546 | $0.549 | $0.512 | $0.529 | 191 270 |
2023-05-02 | $0.534 | $0.580 | $0.531 | $0.550 | 173 497 |
2023-05-01 | $0.497 | $0.550 | $0.475 | $0.550 | 390 798 |
2023-04-28 | $0.474 | $0.486 | $0.474 | $0.483 | 258 638 |
2023-04-27 | $0.499 | $0.499 | $0.474 | $0.474 | 217 720 |
2023-04-26 | $0.500 | $0.500 | $0.470 | $0.474 | 135 482 |
2023-04-25 | $0.490 | $0.498 | $0.460 | $0.480 | 128 311 |
2023-04-24 | $0.475 | $0.498 | $0.475 | $0.482 | 77 038 |
2023-04-21 | $0.464 | $0.500 | $0.464 | $0.485 | 114 635 |
2023-04-20 | $0.495 | $0.511 | $0.480 | $0.480 | 187 255 |
2023-04-19 | $0.490 | $0.520 | $0.490 | $0.500 | 263 987 |
2023-04-18 | $0.513 | $0.519 | $0.493 | $0.506 | 103 924 |
2023-04-17 | $0.500 | $0.523 | $0.490 | $0.510 | 220 916 |
2023-04-14 | $0.540 | $0.548 | $0.511 | $0.512 | 109 581 |
2023-04-13 | $0.510 | $0.546 | $0.500 | $0.514 | 298 051 |
2023-04-12 | $0.560 | $0.560 | $0.502 | $0.525 | 245 772 |
2023-04-11 | $0.533 | $0.553 | $0.460 | $0.540 | 689 306 |
2023-04-10 | $0.560 | $0.560 | $0.530 | $0.550 | 120 692 |
2023-04-06 | $0.590 | $0.600 | $0.540 | $0.550 | 192 050 |
2023-04-05 | $0.620 | $0.640 | $0.580 | $0.600 | 163 078 |
2023-04-04 | $0.612 | $0.630 | $0.590 | $0.613 | 188 084 |
2023-04-03 | $0.650 | $0.650 | $0.623 | $0.640 | 40 143 |
2023-03-31 | $0.640 | $0.655 | $0.622 | $0.640 | 150 960 |
2023-03-30 | $0.660 | $0.660 | $0.610 | $0.634 | 71 563 |
2023-03-29 | $0.612 | $0.640 | $0.600 | $0.627 | 54 567 |
2023-03-28 | $0.647 | $0.675 | $0.606 | $0.631 | 101 363 |
2023-03-27 | $0.644 | $0.660 | $0.620 | $0.647 | 193 561 |
2023-03-24 | $0.600 | $0.663 | $0.549 | $0.644 | 445 483 |
2023-03-23 | $0.580 | $0.590 | $0.540 | $0.570 | 195 493 |
2023-03-22 | $0.588 | $0.600 | $0.580 | $0.585 | 40 500 |
2023-03-21 | $0.580 | $0.610 | $0.580 | $0.590 | 101 681 |
2023-03-20 | $0.520 | $0.599 | $0.520 | $0.587 | 360 449 |
2023-03-17 | $0.580 | $0.580 | $0.523 | $0.532 | 134 297 |
About Aptose Biosciences
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.